Oncology Precision Medicine Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)

Oncology Precision Medicine Market is segmented By Type of Cancer (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer, Gastrointestinal Cancer, Head and Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer, Others), By Route of Administration (Oral, Intravenous, Others), By Type of Molecule (Small Molecules, Biologics), By Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Competitive overview of Oncology Precision Medicine Market

在全球肿瘤精密医学市场运营的主要角色包括安根,BioNTech,Gilead Sciences,Merck & Co.,Illumina, Foundation Medicine, Guardant Health, Caris Life Science, Exact Sciences, Myriad Genetics, Thermo Fisher Science, Invitae, 基因组健康,Syapse和Tempus.

Oncology Precision Medicine Market Leaders

  • 阿斯特拉泽内卡
  • 诺华
  • 辉瑞
  • 布里斯托尔-迈尔斯·斯基布
  • 罗什
*Disclaimer: Major players are listed in no particular order.

Oncology Precision Medicine Market - Competitive Rivalry, 2023

Market Concentration Graph

Oncology Precision Medicine Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights